Bio Solution Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2020	FY 2019
Period Ending	Mar '21 Mar 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Operating Revenue	8,275	7,744	8,882
Other Revenue	-0	-	0
Revenue	8,275	7,744	8,882
Revenue Growth (YoY)	-6.84%	-12.81%	-
Cost of Revenue	3,573	3,498	3,033
Gross Profit	4,702	4,246	5,850
Selling, General & Admin	3,453	3,541	3,436
Research & Development	3,208	3,230	3,645
Amortization of Goodwill & Intangibles	92.97	91.39	84.54
Other Operating Expenses	149.13	147.87	137.2
Operating Expenses	7,499	7,576	7,717
Operating Income	-2,797	-3,330	-1,868
Interest Expense	-47.28	-40.48	-52.6
Interest & Investment Income	1,452	1,427	859.13
Currency Exchange Gain (Loss)	-3.38	-15.13	4.03
Other Non Operating Income (Expenses)	42.76	55.51	12.08
EBT Excluding Unusual Items	-1,353	-1,903	-1,045
Gain (Loss) on Sale of Investments	65.77	103.52	347.5
Pretax Income	-1,283	-1,800	-697.54
Net Income	-1,283	-1,800	-697.54
Net Income to Common	-1,283	-1,800	-697.54
Shares Outstanding (Basic)	24	24	24
Shares Outstanding (Diluted)	24	24	24
Shares Change (YoY)	1.40%	1.29%	-
EPS (Basic)	-53.63	-75.33	-29.57
EPS (Diluted)	-53.69	-75.33	-29.67
Free Cash Flow	-1,660	-3,077	-4,785
Free Cash Flow Per Share	-69.41	-128.79	-202.87
Gross Margin	56.82%	54.83%	65.86%
Operating Margin	-33.80%	-43.00%	-21.03%
Profit Margin	-15.50%	-23.24%	-7.85%
Free Cash Flow Margin	-20.06%	-39.73%	-53.87%
EBITDA	-964.75	-1,529	-331.19
EBITDA Margin	-11.66%	-19.75%	-3.73%
D&A For EBITDA	1,833	1,800	1,536
EBIT	-2,797	-3,330	-1,868
EBIT Margin	-33.80%	-43.00%	-21.03%
Advertising Expenses	-	119.42	89.35

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.